Free Trial

InMed Pharmaceuticals (INM) SEC Filings & 10K Form

InMed Pharmaceuticals logo
$0.26
-0.01 (-3.70%)
(As of 11/1/2024 ET)

Recent InMed Pharmaceuticals SEC Filings

DateFilerForm TypeView
10/28/2024
3:50 PM
InMed Pharmaceuticals (Filer)
Form DEF 14A
10/28/2024
3:00 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
2:25 PM
InMed Pharmaceuticals (Filer)
Form DEFA14A
10/24/2024
2:57 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
11:28 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
5:30 AM
InMed Pharmaceuticals (Filer)
Form 424B3
09/30/2024
12:37 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:10 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
1:04 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
1:00 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
2:08 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
7:32 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
11:48 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:26 PM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
12:30 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
1:39 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
10:26 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
12:44 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
2:20 PM
InMed Pharmaceuticals (Issuer)
MANCINI ALEXANDRA DIANE JANET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
2:20 PM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
2:20 PM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
2:27 PM
InMed Pharmaceuticals (Issuer)
Jagpal Netta (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/22/2024
12:38 PM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
1:58 PM
ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:28 PM
ARMISTICE CAPITAL, LLC (Filed by)
InMed Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2024
11:34 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
1:33 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
1:12 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
12:04 PM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:04 PM
InMed Pharmaceuticals (Issuer)
MANCINI ALEXANDRA DIANE JANET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:05 PM
Baldasare Bryan T (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:07 PM
ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:07 PM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:08 PM
Grove Janet P (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:08 PM
InMed Pharmaceuticals (Issuer)
Tegge Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:09 PM
InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:09 PM
InMed Pharmaceuticals (Issuer)
Lemerond Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:09 PM
InMed Pharmaceuticals (Issuer)
Johnson Shane Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
4:21 PM
InMed Pharmaceuticals (Filer)
Form 10-K/A
12/06/2023
8:02 AM
InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
1:50 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Banking failure dead ahead (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

11/13/2023
11:15 PM
InMed Pharmaceuticals (Filer)
Form EFFECT
11/13/2023
4:05 PM
InMed Pharmaceuticals (Filer)
Form 424B3
11/08/2023
4:05 PM
InMed Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/02/2023
1:56 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INM) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners